Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Fund House: Aditya Birla Sun Life Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 05-07-2019 |
| Asset Class: Equity |
| Benchmark: S&P BSE Healthcare TRI |
| Expense Ratio: 2.52% As on (31-10-2022) |
| Status: Open Ended Schemes |
| Minimum Investment: 1000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 488.9 Cr As on (31-10-2022) |
| Turn over: 26% | Exit Load: 1% for redemption within 30 days |
17.52
0.05 (0.2854%)
17.67%
NIFTY 50 TRI 11.99%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Current Asset Allocation (%)
Indicators
| Volatility | |
| Sharp Ratio | 0.78 |
| Alpha | -1.57 |
| Beta | 0.89 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
23.38%
Others
3.86%
Large Cap
53.19%
Mid Cap
19.58%
Tax Benefits of investing in this fund
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund
